| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.34 | 0.04 |